Archives
Many Medicaid Enrollees Have Restricted Access to SGLT2 Inhibitors, GLP-1 Receptor Agonists
Proportion of adult managed care organizations with availability varied from 24 to 100 percent for SGLT2 inhibitors, 0 to 99 percent for GLP-1 receptor agonists
Statin Use Improves Outcomes in Chronic, Small Lymphocytic Leukemia
Improvements seen in overall survival, progression-free survival, and cancer-specific survival
Mental Health, Neurodevelopmental Diagnoses in Publicly Insured Children on the Rise
Findings seen for most diagnostic categories, including attention-deficit/hyperactivity, anxiety, autism spectrum, and depressive disorders
Adult Acne Linked to Higher Risk for Eating Disorders
Findings attenuated but still significant after allowing for history of anxiety, depression, body dysmorphic disorder
Psoriatic Arthritis Tied to Delays in Diagnosis Compared With Rheumatoid Arthritis
Patients with psoriatic arthritis are less likely to begin disease-modifying antirheumatic drug therapy
2019 to 2023 Saw Increase in Prevalence of Psilocybin Use in the United States
Increase seen in lifetime use among adults and adolescents; past-year use higher among young adults, older adults
Nearly One in Four Families of Children With Disabilities Face Financial Hardships
These families are also more likely to delay or forgo health care
Outcomes With Immune Checkpoint Inhibitors Similar for Older, Younger Patients
Older patients have divergent immune phenotypes at baseline that persist during immune checkpoint inhibitor therapy
Intensive BP Reduction Effective for Lowering All-Cause Dementia Risk
Findings seen among 33,995 individuals aged 40 years and older with untreated hypertension
Hydroxyurea Has Sustained Clinical Benefits in Children With Sickle Cell Anemia
Fewer ED visits per year and fewer hospital days per year seen in association with hydroxyurea use
